Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund [...]
With approval in sight, ObsEva sells regional rights to women’s health drug for tiny upfront
With approval in sight, ObsEva sells regional rights to women’s [...]
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an interest in psilocybin
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an [...]
Curevo will go head-to-head against GSK’s Shingrix thanks to new $60M financing
Curevo will go head-to-head against GSK’s Shingrix thanks to new [...]
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another nail in tenapanor’s coffin
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another [...]
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a [...]
Checkmate plucks BMS exec Bash to be new CEO
Checkmate plucks BMS exec Bash to be new CEO mbayer [...]
Rivus throws down mid-stage liver fat data on quest to climb NASH mountain
Rivus throws down mid-stage liver fat data on quest to [...]
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory [...]
Axsome’s migraine drug finally slated for FDA inspection but investors really want to know about stalled depression therapy
Axsome’s migraine drug finally slated for FDA inspection but investors [...]